• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Phillips-Medisize to build drug delivery manufacturing facility in Wisconsin

December 12, 2016 By Sarah Faulkner

Phillips-Medisize to build drug delivery manufacturing facility in WisconsinPhillips-Medisize said today that it plans to open an 80,000 square foot drug delivery manufacturing facility at its Menomonie, Wisconsin campus. The facility, which is expected to open in 2017, will manufacture high volume, prefilled drug delivery systems. It will employ at least 100 people, the company said, and is funded by the signing of a new supply contract with an undisclosed biopharmaceutical company.

The site’s expansion is the latest in a series over the past 4 years. Last November, Phillips-Medisize doubled the size of its New Richmond, Wisconsin medical device facility and earlier this year, the company opened a 17,000 square foot clinical and pilot build facility for drug delivery combination products in Menomonie, Wisconsin.

“This expansion illustrates our continued commitment and investment in the design and manufacturing of drug delivery devices for biopharmaceutical companies, globally. Expanding in Menomonie adds to our manufacturing capacity to produce fully assembled and packaged drug delivery devices,” president & CEO Matt Jennings said in prepared remarks. “We are proud of this leading-edge manufacturing campus featuring advanced molding and assembly, cold-chain drug handling, serialization technologies and FDA-registered dedicated clinical and pilot build facilities for drug delivery and finished combination products.”

“The recent acquisition of Phillips-Medisize by Molex bolsters our ability to provide comprehensive end-to-end electronics solutions as part of our drug delivery device capabilities. Customer response to our addition of Molex electronics capabilities has been tremendous,” Jennings added.

Filed Under: Drug-Device Combinations, Featured Tagged With: Phillips-Medisize

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS